ZIOPHARM Oncology Inc (NASDAQ:ZIOP)
| 2.62 Data as of May 24 |  +0.60 / +29.75%Today’s Change | 1.49 Today|||52-Week Range 6.33 | -37.00% Year-to-Date |
Latest ZIOP News | Press Releases
No recent news for ZIOPHARM Oncology Inc.
Today’s Trading
| Previous close | 2.02 |
| Today’s open | 2.10 |
| Day’s range | 2.08 - 2.96 |
| Volume | 16,771,548 |
| Average volume (3 months) | 2,293,950 |
| Market cap | $168.8M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | -25.77% |
| Earnings growth (this year) | +25.41% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +19.94% |
| P/E ratio | NM |
| Price/Sales | 408.44 |
| Price/Book | 3.47 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FOLDAmicus Therapeutics ... | -0.02 | -0.58% |
| ARQLArQule Inc | -0.02 | -0.73% |
| OMTHOmthera Pharmaceutic... | -0.33 | -4.65% |
| TTPHTetraphase Pharmaceu... | -0.04 | -0.51% |
Data as of 4:00pm ET, 05/24/2013
Financials
| Next reporting date | August 2, 2013 |
| EPS forecast (this quarter) | -$0.24 |
| Annual revenue (last year) | $800.0K |
| Annual profit (last year) | -$96.1M |
| Net profit margin | -12,016.50% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director Jonathan J. Lewis, PhD, MD |
Chief Financial Officer & Executive Vice President Jason A. Amello, CPA |
Corporate headquarters New York, New York |
Forecasts
